Prothena Corporation plc
77 Sir John Rogerson’s Quay, Block C
Grand Canal Docklands
Dublin 2, D02 T804, Ireland
June 18, 2019
VIA EDGAR TRANSMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, DC 20549
Attention: | Frank Wyman | |
Tabatha McCullom | ||
Re: | Prothena Corporation plc | |
Form 10-K for the Year Ended December 31, 2017 | ||
Filed February 26, 2018 | ||
Form 10-Q for the Quarterly Period Ended September 30, 2018 | ||
Filed November 6, 2018 | ||
File No. 001-35676 |
Ladies and Gentlemen:
This letter is to confirm the receipt of your letter dated May 29, 2019 (the “SEC Comment Letter”) regarding the Annual Report on Form 10-K for the year ended December 31, 2017 and the Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018 of Prothena Corporation plc (the “Company”). The Company plans to provide you with a response to the SEC Comment Letter on or before June 26, 2019.
If you have any questions regarding the foregoing, please call John C. Williams of Latham & Watkins LLP at (650) 470-4887 or the undersigned at (650) 615-2113.
Very truly yours, |
/s/ A. W. Homan |
A. W. Homan |
Chief Legal Officer and Company Secretary |
cc: | Tran B. Nguyen |
Karin Walker
Kathleen Wells